Abstract:Ensuring the safety and efficacy of chemical compounds is crucial in small-molecule drug development. In the later stages of drug development, toxic compounds pose a significant challenge, losing valuable resources and time. Early and accurate prediction of compound toxicity using deep learning models offers a promising solution to mitigate these risks during drug discovery. In this study, we present the development of several deep-learning models aimed at evaluating different types of compound toxicity, including acute toxicity, carcinogenicity, hERG_cardiotoxicity (the human ether-a-go-go related gene caused cardiotoxicity), hepatotoxicity, and mutagenicity. To address the inherent variations in data size, label type, and distribution across different types of toxicity, we employed diverse training strategies. Our first approach involved utilizing a graph convolutional network (GCN) regression model to predict acute toxicity, which achieved notable performance with Pearson R 0.76, 0.74, and 0.65 for intraperitoneal, intravenous, and oral administration routes, respectively. Furthermore, we trained multiple GCN binary classification models, each tailored to a specific type of toxicity. These models exhibited high area under the curve (AUC) scores, with an impressive AUC of 0.69, 0.77, 0.88, and 0.79 for predicting carcinogenicity, hERG_cardiotoxicity, mutagenicity, and hepatotoxicity, respectively. Additionally, we have used the approved drug dataset to determine the appropriate threshold value for the prediction score in model usage. We integrated these models into a virtual screening pipeline to assess their effectiveness in identifying potential low-toxicity drug candidates. Our findings indicate that this deep learning approach has the potential to significantly reduce the cost and risk associated with drug development by expediting the selection of compounds with low toxicity profiles. Therefore, the models developed in this study hold promise as critical tools for early drug candidate screening and selection.

Predicting adverse drug reactions through interpretable deep learning framework

BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs

Advancing Adverse Drug Reaction Prediction with Deep Chemical Language Model for Drug Safety Evaluation

Deep Learning Prediction of Adverse Drug Reactions Using Open TG-GATEs and FAERS Databases

Prediction of Adverse Drug Reactions by Combining Biomedical Tripartite Network and Graph Representation Model.

Research on Adverse Drug Reaction Prediction Model Combining Knowledge Graph Embedding and Deep Learning

Prediction of adverse drug reactions due to genetic predisposition using deep neural networks

Predicting Drugs Suspected of Causing Adverse Drug Reactions Using Graph Features and Attention Mechanisms

Drug-Target Indication Prediction by Integrating End-to-End Learning and Fingerprints

Abstract 4923: A systematic framework for predicting adverse drug reaction signals using medical data

ADRNet: A Generalized Collaborative Filtering Framework Combining Clinical and Non-Clinical Data for Adverse Drug Reaction Prediction

Prediction of adverse drug reactions based on knowledge graph embedding

Prediction of adverse drug reactions using demographic and non-clinical drug characteristics in FAERS data

Predicting Adverse Drug Reactions from Social Media Posts: Data Balance, Feature Selection and Deep Learning

An Adaptive Graph Learning Method for Automated Molecular Interactions and Properties Predictions

Developing A Deep Learning Natural Language Processing Algorithm For Automated Reporting Of Adverse Drug Reactions

Predicting drug-induced liver injury using graph attention mechanism and molecular fingerprints

Deep learning for drug‐drug interaction prediction: A comprehensive review

A deep learning based multi-model approach for predicting drug-like chemical compound's toxicity

A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network

ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches